Australia markets closed

Shandong Boan Biotechnology Co., Ltd. (UJ9.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.1500+0.0100 (+0.88%)
At close: 03:29PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
618,129
618,129
515,960
158,704
0
Cost of revenue
209,161
209,161
161,730
52,190
0
Gross profit
408,968
408,968
354,230
106,514
0
Operating expenses
Research development
230,682
230,682
400,338
231,567
236,317
Selling general and administrative
308,220
308,220
296,420
96,213
1,906
Total operating expenses
513,134
513,134
680,457
323,516
229,323
Operating income or loss
-104,166
-104,166
-326,227
-217,002
-229,323
Interest expense
14,087
14,087
13,407
11,599
11,819
Income before tax
-119,377
-119,377
-331,749
-225,417
-240,538
Income tax expense
0
0
0
0
0
Income from continuing operations
-119,377
-119,377
-331,749
-225,417
-240,538
Net income
-119,377
-119,377
-331,749
-225,417
-240,538
Net income available to common shareholders
-119,377
-119,377
-331,749
-225,417
-240,538
Basic EPS
-0.59
-0.23
-0.67
-0.44
-0.47
Diluted EPS
-0.59
-0.23
-0.67
-0.44
-0.47
Basic average shares
509,278
509,278
498,613
509,278
509,278
Diluted average shares
509,278
509,278
498,613
509,278
509,278